| Description | mRNA microarray expression profiles for cancer cell lines |
| Measurement | gene expression by microarray |
| Association | gene-cell line associations by differential expression of gene across cell lines |
| Category | transcriptomics |
| Resource | Genomics of Drug Sensitivity in Cancer |
| Citation(s) | |
| Last Updated | 2015 Apr 06 |
| Stats |
|
Attribute Similarity
Gene Attribute
Gene Similarity
624 sets of genes with high or low expression in each cell line relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
| Gene Set | Description |
|---|---|
| 23132-87 | |
| 5637 | |
| 639-V | disease: carcinoma, transitional cell |
| 647-V | |
| 697 | Human B cell precursor leukemia; established from the bone marrow of a 12-year-old boy with acute lymphoblastic leukemia (cALL) at relapse in 1979. |
| 786-0 | This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors. |
| 8-MG-BA | |
| 8505C | Established from undifferentiated thyroid carcinomas of a 78 year old female patient. |
| A101D | |
| A172 | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.). |
| A204 | |
| A2058 | Human skin melanoma cell line, established from a 43 years adult caucasian male. |
| A253 | |
| A2780 | Human ovarian carcinoma cell line. |
| A3-KAW | |
| A375 | |
| A4-Fuk | |
| A427 | |
| A431 | Human epidermoid carcinoma established from the solid tumor of an 85-year-old woman; cells were reported to have large numbers of EGF binding sites; cell line was used as indicator cell line for anti-TGF binding. |
| A498 | |
| A549 | Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin. |
| A673 | |
| A704 | Human kidney adenocarcinoma cell line, established from a 78 years old male. |
| ABC-1 | |
| ACHN | |
| ACN | |
| AGS | |
| ALL-PO | |
| AM-38 | |
| AN3-CA | |
| ARH-77 | Human plasma cell leukemia cell line, established from the peripheral blood of a 33-year-old woman with IgG plasma cell leukemia; cell line is widely used as model for multiple myeloma/plasma cell leukemia, but cells are clearly EBV+ indicating that ARH-77 might be rather a normal B-lymphoblastoid cell line than a tumor cell line. |
| AsPC-1 | |
| ATN-1 | A immortal human blood cell line cell that has the characteristics: Adult T-cell leukemia. HTLV-1 pro-virus DNA(+). |
| BALL-1 | Human acute lymphoblastoid leukemia cell line from peripheral blood. |
| BB30-HNC | |
| BB49-HNC | |
| BB65-RCC | |
| BC-1 | |
| BC-3 | |
| BCPAP | Human papillary thyroid carcinoma derived cell line. |
| BE-13 | |
| Becker | |
| BEN | Human lung carcinoma; established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung. |
| BFTC-905 | |
| BFTC-909 | disease: carcinoma, transitional cell |
| BHT-101 | |
| BHY | Oral squamous cell carcinoma cell line. |
| BL-41 | Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma. |
| BPH-1 | Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens. |
| BT-20 | Human, Caucasian, breast, carcinoma cell line. Morphology: epithelial-like; species: human, Caucasian female 74 years old; tissue: breast; tumor: carcinoma. |
| BT-549 | |
| BV-173 | |
| BxPC-3 | Human pancreatic adenocarcinoma cell line, established from a 61 year old human female. |
| C2BBe1 | The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution. |
| C32 | |
| C3A | |
| Ca-Ski | A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.). |
| CA46 | |
| Ca9-22 | A immortal human gingiva-derived cell line cell that has the characteristics: Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.). |
| CAKI-1 | |
| CAL-120 | disease: adenocarcinoma, breast |
| CAL-12T | |
| CAL-148 | disease: adenocarcinoma, breast |
| CAL-27 | Human tongue squamous cell carcinoma established from the poorly differentiated squamous cell carcinoma of the tongue removed from a 56-year-old man before treatment in 1982. |
| CAL-33 | Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy). |
| CAL-39 | disease: carcinoma, squamous cell |
| CAL-51 | |
| CAL-54 | |
| CAL-62 | |
| CAL-85-1 | disease: adenocarcinoma, breast |
| Calu-3 | |
| Calu-6 | |
| CAMA-1 | |
| Caov-3 | |
| Caov-4 | disease: adenocarcinoma (ovary primary) |
| CAPAN-1 | |
| CaR-1 | Human rectal carcinoma cell line. |
| CAS-1 | |
| CCF-STTG1 | |
| CCRF-CEM | |
| CESS | |
| CFPAC-1 | This line was derived from a pancreatic duct adenocarcinoma (liver metastasis) from a patient with cystic fibrosis. |
| CGTH-W-1 | |
| ChaGo-K-1 | |
| CHL-1 | |
| CHP-134 | A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc gene amplification |
| CHP-212 | |
| COLO-205 | |
| COLO-320-HSR | disease: colorectal adenocarcinoma |
| COLO-668 | disease: carcinoma, oat cell |
| COLO-678 | |
| COLO-679 | |
| COLO-680N | disease: carcinoma, squamous cell |
| COLO-684 | |
| COLO-741 | disease: carcinoma, colon |
| COLO-792 | disease: malignant melanoma |
| COLO-800 | |
| COLO-824 | |
| COR-L105 | |
| COR-L23 | disease: carcinoma, large cell |
| COR-L279 | disease: carcinoma, small cell |
| COR-L88 | disease: carcinoma, lung small cell |
| CP66-MEL | |
| CP67-MEL | |
| CPC-N | disease: carcinoma, small cell |
| CRO-AP2 | |
| CTB-1 | A immortal human cell line cell that has the characteristics: Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis. |
| CTV-1 | disease: leukemia, acute myeloid |
| CW-2 | A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable. |
| D-247MG | |
| D-263MG | |
| D-283MED | |
| D-336MG | |
| D-392MG | |
| D-423MG | |
| D-502MG | |
| D-542MG | |
| D-566MG | |
| Daoy | The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy. |
| Daudi | A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011. |
| DB | disease: large cell lymphoma |
| DBTRG-05MG | |
| DEL | |
| DG-75 | |
| DJM-1 | A immortal human zone of skin-derived cell line cell that has the characteristics: Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable. |
| DK-MG | |
| DMS-114 | |
| DMS-273 | disease: carcinoma, small cell |
| DMS-53 | |
| DOHH-2 | |
| DOK | |
| DoTc2-4510 | |
| DSH1 | |
| DU-145 | A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.). |
| DU-4475 | disease: ductal carcinoma |
| EB-3 | disease: Burkitts lymphoma |
| EB2 | disease: Burkitts lymphoma (B lymphocyte primary) |
| EC-GI-10 | A immortal human esophagus-derived cell line cell that has the characteristics: Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing. |
| ECC12 | A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. |
| EFM-19 | |
| EFO-21 | disease: cystoadenocarcinoma |
| EFO-27 | Human ovary adenocarcinoma cell line; established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979. |
| EGI-1 | |
| EHEB | Human chronic B cell leukemia cell line;established from the peripheral blood of a 69-year-old woman with B-CLL (chronic lymphocytic leukemia) prior treatment by EBV-transformation in 1988; cell line may represent rather a B-lymphoblastoid cell line than a bona fide B-CLL cell line. |
| EKVX | Non-small cell lung adenocarcinoma cell line. |
| EM-2 | disease: leukemia, chronic myeloid |
| EoL-1-cell | Human eosinophilic leukaemia cell line. |
| EPLC-272H | disease: carcinoma, epidermoid |
| ES1 | |
| ES3 | |
| ES5 | |
| ES6 | |
| ES7 | |
| ES8 | |
| ESS-1 | disease: sarcoma-stromal |
| ETK-1 | |
| EVSA-T | |
| EW-1 | |
| EW-11 | |
| EW-12 | |
| EW-13 | |
| EW-16 | |
| EW-18 | |
| EW-22 | |
| EW-24 | |
| EW-3 | |
| EW-7 | |
| FADU | Cell line derived from squamous cell carcinoma of the hypopharynx. |
| FTC-133 | Human thyroid carcinoma cell line; obtained from a lymph node metastasis of a follicular thyroid carcinoma from a 42-year-old male. |
| G-361 | Homo sapiens (human); skin; malignant melanoma cell line; established from a 31 year old caucasian male. |
| G-401 | A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney |
| GAK | cyclin G associated kinase|In all eukaryotes, the cell cycle is governed by cyclin-dependent protein kinases (CDKs), whose activities are regulated by cyclins and CDK inhibitors in a diverse array of mechanisms that involve the control of phosphorylation and dephosphorylation of Ser, Thr or Tyr residues. Cyclins are molecules that possess a consensus domain called the 'cyclin box.' In mammalian cells, 9 cyclin species have been identified, and they are referred to as cyclins A through I. Cyclin G is a direct transcriptional target of the p53 tumor suppressor gene product and thus functions downstream of p53. GAK is an association partner of cyclin G and CDK5. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013] |
| GAMG | Human glioblastoma cell line. |
| GCIY | A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer (Borrmann IV). Mutin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow. |
| GCT | A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis |
| GI-1 | A immortal human brain-derived cell line cell that has the characteristics: Human glioma separated from gliosarcoma. |
| GI-ME-N | |
| GMS-10 | disease: glioblastoma |
| GOTO | Human glioblastoma cell line. |
| GP5d | |
| GR-ST | A immortal human blood cell line cell that has the characteristics: RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF. |
| GT3TKB | |
| H-EMC-SS | disease: chondrosarcoma |
| H4 | |
| H9 | |
| HC-1 | disease: leukemia, hairy cell |
| HCC1143 | disease: primary ductal carcinoma |
| HCC1187 | disease: primary ductal carcinoma |
| HCC1395 | |
| HCC1419 | disease: primary ductal carcinoma |
| HCC1599 | disease: primary ductal carcinoma |
| HCC1806 | disease: primary acantholytic squamous cell carcinoma |
| HCC1937 | |
| HCC1954 | |
| HCC2157 | disease: primary ductal carcinoma |
| HCC2218 | disease: primary ductal carcinoma |
| HCC2998 | |
| HCC38 | |
| HCC70 | disease: primary ductal carcinoma |
| HCE-4 | Human esophageal carcinoma cell line. |
| HCT-116 | Human colon colorectal carcinoma cell line from a male organism. Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man. |
| HCT-15 | |
| HD-MY-Z | |
| HDLM-2 | |
| HEC-1 | |
| HEL | Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis. |
| HGC-27 | This human gastric carcinoma cell line was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histological as undifferentiated carcinoma. |
| HH | |
| HL-60 | Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976. |
| HLE | Human lens epithelial cell line. |
| HMV-II | A immortal human cell line cell that has the characteristics: Melanin producing. Originated from the same site of HMV-I. |
| HN | Oral squamous cell carcinoma cell line. |
| HO-1-N-1 | |
| HOP-62 | Non-small cell lung adenocarcinoma cell line. |
| HOP-92 | Non-small cell lung adenocarcinoma cell line. |
| HOS | |
| HPAF-II | |
| Hs-578-T | |
| HSC-2 | A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.). |
| HSC-3 | A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484(Deposited from Tohoku Univ.). |
| HSC-4 | A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.). |
| HT | disease: diffuse mixed lymphoma; B lymphoblast |
| HT-1080 | |
| HT-1197 | |
| HT-1376 | |
| HT-144 | Homo sapiens (human), morphology: fibroblast, tissue: metastatic site: subcutaneous tissue malignant melanoma, established from a 29-year-old caucasian men. |
| HT-29 | |
| HT-3 | disease: carcinoma (cervix primary) |
| HT55 | |
| HTC-C3 | A immortal human thyroid gland-derived cell line cell that has the characteristics: Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin |
| HuCCT1 | A immortal human cell line cell that has the characteristics: Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.). |
| HuH-7 | HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. |
| HuO-3N1 | A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.). |
| HuO9 | |
| HuP-T3 | |
| HuP-T4 | |
| HUTU-80 | |
| IA-LM | A immortal human cell line cell that has the characteristics: Japanese lung large cell carcinoma |
| IGR-1 | |
| IGROV-1 | |
| IM-9 | Human B lymphoblastoid cell line (from patient with multiple myeloma); established from the bone marrow of a woman with multiple myeloma in 1967. Although derived from the blood of a patient with multiple myeloma, this line has been shown to be an EBV-transformed B lymphoblastoid cell line. |
| IMR-5 | |
| IPC-298 | |
| IST-MEL1 | |
| IST-MES1 | disease: mesothelioma |
| IST-SL1 | disease: carcinoma, small cell |
| IST-SL2 | disease: carcinoma, small cell |
| J-RT3-T3-5 | disease: acute T cell leukemia |
| J82 | |
| JAR | |
| JEG-3 | |
| JiyoyeP-2003 | |
| JVM-2 | disease: leukemia, chronic, B cell |
| JVM-3 | disease: leukemia, chronic, B cell |
| K5 | |
| KALS-1 | |
| KARPAS-299 | |
| KARPAS-422 | Human B cell lymphoma cell line; established from the pleural effusion of a 73-year-old woman with B cell non-Hodgkin lymphoma (intraabdominal, diffuse large cell lymphoma, refractory, terminal) in 1987. |
| KARPAS-45 | disease: leukemia, T cell |
| KASUMI-1 | Human acute myelocytic leukemia cell line; derived from the peripheral blood of a 7-year-old japanese boy with acute myelocytic leukemia in relapse after bone marrow transplantation. |
| KE-37 | Human T cell leukemia cell line; established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979. |
| KGN | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow. |
| KINGS-1 | |
| KM-H2 | Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974. |
| KM12 | Human colon carcinoma cell line. |
| KMOE-2 | disease: erythremia acute |
| KNS-42 | |
| KNS-62 | |
| KNS-81-FD | |
| KOSC-2 | |
| KP-4 | A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3. |
| KP-N-RT-BM-1 | |
| KP-N-YN | Human neuroblastoma cell line. |
| KP-N-YS | |
| KS-1 | |
| KU-19-19 | disease: carcinoma, transitional cell |
| KURAMOCHI | |
| KY821 | |
| KYSE-140 | disease: carcinoma, squamous cell |
| KYSE-150 | Human esophageal squamous cell carcinoma cell line; established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy. |
| KYSE-270 | disease: carcinoma, squamous cell |
| KYSE-410 | disease: carcinoma, squamous cell |
| KYSE-450 | disease: carcinoma, squamous cell |
| KYSE-510 | disease: carcinoma, squamous cell |
| KYSE-520 | disease: carcinoma, squamous cell |
| KYSE-70 | disease: carcinoma, squamous cell |
| L-363 | Multiple myeloma cell line expressing syndecan-1. |
| L-428 | |
| L-540 | |
| LAMA-84 | Human chronic myeloid leukemia in blast crisis; established from the peripheral blood of a 29-year-old woman with chronic myeloid leukemia. |
| LAN-6 | |
| LB1047-RCC | |
| LB2241-RCC | |
| LB2518-MEL | |
| LB373-MEL-D | |
| LB647-SCLC | |
| LB771-HNC | |
| LB831-BLC | |
| LB996-RCC | |
| LC-1F | A immortal human cell line cell that has the characteristics: Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq. |
| LC4-1 | B-precursor acute lymphoblastic leukemia cell line. |
| LCLC-103H | disease: carcinoma, large cell |
| LCLC-97TM1 | disease: carcinoma, large cell |
| LK-2 | A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line.TKG0494 (Deposited from Tohoku Univ.). |
| LN-405 | |
| LNCaP-Clone-FGC | disease: carcinoma (prostate primary) |
| LOUCY | disease: T lymphocyte; acute lympho- blastic leukemia; t(16;20) translocation |
| LoVo | A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow. |
| LOXIMVI | Human melanoma cell line. |
| LS-1034 | disease: colorectal carcinoma |
| LS-123 | |
| LS-411N | disease: colorectal carcinoma |
| LS-513 | disease: colorectal carcinoma |
| LU-134-A | A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-B. |
| LU-135 | A immortal human cell line cell that has the characteristics: Small cell carcinoma, variant type |
| LU-139 | A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type |
| LU-65 | A immortal human cell line cell that has the characteristics: Human lung carcinoma cell line. TKG0442(Deposited from Tohoku Univ.). |
| LU-99A | |
| LXF-289 | |
| M059J | disease: malignant glioblastoma; glioma |
| M14 | The human melanoma cell line M14 has been established from surgically removed melanoma metastases. |
| MC-IXC | |
| MCF7 | A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.). |
| MDA-MB-157 | disease: carcinoma (mammary gland primary) |
| MDA-MB-175-VII | |
| MDA-MB-231 | |
| MDA-MB-361 | |
| MDA-MB-415 | disease: adenocarcinoma (mammary gland primary) |
| MDA-MB-453 | |
| MDA-MB-468 | |
| ME-180 | disease: epidermoid carcinoma (cervix primary) |
| MEG-01 | |
| MEL-HO | Human melanoma; established from the primary tumor of a woman with melanoma in 1976; cells express mRNA of the oncogene c-myc. |
| MEL-JUSO | Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977. |
| MES-SA | disease: uterine sarcoma |
| Mewo | Human skin malignant melanoma cell line. |
| MFE-280 | |
| MFE-296 | |
| MFH-ino | A immortal human cell line cell that has the characteristics: Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features. |
| MFM-223 | Human breast carcinoma; established from the pleural effusion of a post-menopausal breast cancer patient without any prior treatment (tumor: widespread ductal mammary carcinoma T4 N2 M1 with histological grade III); cells were described to express androgen, estrogen and progesterone receptors. |
| MG-63 | |
| MHH-CALL-2 | disease: leukemia, pre-B cell |
| MHH-ES-1 | |
| MHH-NB-11 | |
| MHH-PREB-1 | |
| MIA-PaCa-2 | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.) |
| MKN1 | A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells. |
| MKN28 | Well differentiated human gastric adenocarcinoma cell line. |
| MKN45 | Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman. |
| MKN7 | A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type. |
| ML-2 | |
| MMAC-SF | |
| MN-60 | disease: leukemia, B cell |
| MOLT-13 | Human T cell leukemia cell line; established from the bone marrow of a 2-year-old girl with T-ALL (T cell acute lymphoblastic leukemia, FAB L2) at relapse in 1983. |
| MOLT-16 | |
| MOLT-4 | |
| MONO-MAC-6 | Human acute monocytic leukemia cell line; established from the peripheral blood of a 64-year-old man with relapsed acute monocytic leukemia (AML FAB M5) in 1985 following myeloid metaplasia. Sister cell line of MONO-MAC-1. |
| MPP-89 | disease: mesothelioma |
| MRK-nu-1 | Human mammary gland carcinoma cell line, established from a 46 years old female. |
| MS-1 | |
| MSTO-211H | Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy. |
| MZ2-MEL | |
| MZ7-mel | |
| NALM-6 | |
| NB10 | |
| NB12 | |
| NB13 | |
| NB14 | Human neuroblastoma tumor cell line. |
| NB17 | |
| NB5 | Human neuroblastoma tumor cell line. |
| NB6 | |
| NB69 | A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene unamplified tumor. Cell growth is slow. |
| NB7 | Human neuroblastoma cell line. |
| NBsusSR | A immortal human cell line cell that has the characteristics: Isolated from a patient with hiper dopaminemia andnorepinephrinemia. |
| NCI-H1048 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H1092 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1155 | |
| NCI-H1299 | |
| NCI-H1355 | |
| NCI-H1395 | |
| NCI-H1437 | |
| NCI-H1563 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1573 | disease: adenocarcinoma (lung primary) |
| NCI-H1650 | |
| NCI-H1666 | disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary) |
| NCI-H1693 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1703 | |
| NCI-H1755 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1770 | disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary) |
| NCI-H1792 | disease: adenocarcinoma (lung primary) |
| NCI-H1793 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1838 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1975 | |
| NCI-H1993 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2009 | |
| NCI-H2029 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2030 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2052 | disease: mesothelioma (pleura primary) |
| NCI-H2081 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H2087 | |
| NCI-H209 | Small cell lung cancer cell line. |
| NCI-H2126 | |
| NCI-H2141 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2170 | |
| NCI-H2171 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2196 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2227 | disease: carcinoma; small cell lung cancer |
| NCI-H2228 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H226 | |
| NCI-H2291 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H23 | |
| NCI-H2342 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H2347 | |
| NCI-H2405 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2452 | disease: mesothelioma |
| NCI-H250 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H28 | disease: mesothelioma (pleura primary) |
| NCI-H292 | Mucoepidermoid human lung carcinoma cell line; established from a black female 32 years old; Morphology: epithelial. |
| NCI-H345 | Small cell lung cancer cell line. |
| NCI-H358 | |
| NCI-H378 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H441 | |
| NCI-H446 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H460 | |
| NCI-H510A | disease: carcinoma; small cell lung cancer (unknown primary) |
| NCI-H520 | |
| NCI-H522 | |
| NCI-H524 | |
| NCI-H526 | Human small cell lung cancer cell line; established from a 55 years old caucasian male. |
| NCI-H596 | Human lung adenosquamous carcinoma cell line; derived in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung. |
| NCI-H630 | disease: carcinoma (rectum primary) |
| NCI-H64 | |
| NCI-H650 | disease: bronchioalveolar carci- noma; non-small cell lung cancer (lung primary) |
| NCI-H661 | |
| NCI-H716 | |
| NCI-H727 | disease: carcinoid |
| NCI-H747 | disease: colorectal adenocarcinoma |
| NCI-H810 | disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer |
| NCI-H82 | |
| NCI-H838 | |
| NCI-N87 | |
| NCI-SNU-1 | |
| NCI-SNU-16 | |
| NCI-SNU-5 | |
| NEC8 | A immortal human testis-derived cell line cell that has the characteristics: Embryonal carcinoma, testis. |
| NH-12 | A immortal somatic nervous system-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.). |
| NKM-1 | |
| NMC-G1 | |
| no-10 | |
| no-11 | |
| NOMO-1 | |
| NOS-1 | A immortal human bone element-derived cell line cell that has the characteristics: Osteoid producing in vitro and in nude mice. Cell growth is slow. |
| NUGC-3 | Human gastric adenocarcinoma cell line established from a 72-year-old male. |
| NY | |
| OAW-28 | |
| OAW-42 | disease: cystoadenocarcinoma |
| OC-314 | disease: cystoadenocarcinoma, low differentiated, papillary serous; G2/3 FIGO stage III c |
| OCI-AML2 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 65-year-old man with acute myeloid leukemia. |
| OCUB-M | A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid. |
| OE19 | |
| OE33 | |
| OMC-1 | A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix squamous cell carcinoma. Once said TA-4 positive. |
| ONS-76 | |
| OPM-2 | |
| OS-RC-2 | A immortal human kidney-derived cell line cell that has the characteristics: Renal tumor cell from a Japanese. Transplantable to nude mice. |
| OVCAR-3 | |
| OVCAR-4 | |
| OVCAR-5 | |
| OVCAR-8 | |
| P12-ICHIKAWA | Human T cell leukemia; established from the peripheral blood of a 7-year-old boy with acute lymphoblastic leukemia (ALL). |
| P30-OHK | A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.). |
| P31-FUJ | |
| PA-1 | Human ovary ascites teratocarcinoma cell line. The line was established from cells taken from ascitic fluid. |
| PANC-03-27 | |
| PANC-08-13 | |
| PANC-10-05 | disease: adenocarcinoma; same patient as PL45 |
| PC-14 | |
| PC-3 | |
| PF-382 | |
| PFSK-1 | disease: malignant primitive neuroectodermal tumor |
| PSN1 | Human pancreatic adenocarcinoma cell line. |
| QIMR-WIL | disease: leukemia, myeloblastic |
| Raji | |
| Ramos-2G6-4C10 | disease: Burkitts lymphoma (American) |
| RCC10RGB | A immortal human kidney-derived cell line cell that has the characteristics: Kidney carcinoma from a Japanese patient. Cell growth is slow. |
| RCM-1 | |
| RD | |
| REH | Human B cell precursor leukemia established from the peripheral blood of a 15-year-old North African girl with acute lymphoblastic leukaemia, ALL at first relapse, in 1973. |
| RERF-LC-MS | |
| RH-1 | Human rhabdomyosarcoma cell line. |
| RH-18 | Human rhabdomyosarcoma cell line. |
| RKO | |
| RL | |
| RMG-I | Human tumor cell line from ovarian mesonephroid adenocarcinoma. |
| RO82-W-1 | |
| RPMI-2650 | Human nasal septum squamous cell carinoma cell line; established from the pleural effusion of a 52-year-old man with anaplastic squamous cell carcinoma of the nasal septum in 1962. |
| RPMI-6666 | disease: Hodgkins disease |
| RPMI-7951 | Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node. |
| RPMI-8226 | |
| RPMI-8402 | Human T cell acute lymphoblastic leukemia cell line; established from the peripheral blood of a 16-year-old woman with acute lymphoblastic leukemia (ALL) in 1972. |
| RPMI-8866 | Human B lymphoid cell line, established from the peripheral blood of a 51-year-old American woman with chronic myelogenous leukemia in May 1966. |
| RS4-11 | Human B cell precursor leukemia cell line; established from the bone marrow of a 32-year-old woman with acute lymphoblastic leukemia (ALL L2) in first relapse. |
| RT-112 | Human urinary bladder transitional cell carcinoma established from the transitional cell carcinoma histological grade G2 excised from a female patient with untreated primary urinary bladder carcinoma in 1973. |
| RVH-421 | |
| RXF393 | Renal cancer cell line. |
| S-117 | |
| Saos-2 | Human osteogenic sarcoma, established from the primary osteogenic sarcoma of an 11-year-old Caucasian woman in 1973. |
| SAS | A immortal human tongue-derived cell line cell that has the characteristics: Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470(Deposited from Tohoku Univ.). |
| SBC-1 | Human small cell lung cancer cell line. |
| SBC-5 | |
| SCC-15 | Human tongue squamous cell carcinoma cell line. |
| SCC-25 | Human squamous cell carcinoma cell line; established from the biopsy of a squamous cell carcinoma of the tongue of a 70-year-old man. |
| SCC-3 | |
| SCC-4 | Human squamous cell carcinoma cell line; established from the squamous cell carcinoma of the tongue from a 55-year-old man after radio- and chemotherapy in 1980. |
| SCC-9 | disease: squamous cell carcinoma |
| SCH | |
| SF126 | |
| SF268 | |
| SF295 | |
| SF539 | |
| SHP-77 | |
| SiHa | |
| SIMA | |
| SJRH30 | disease: rhabdomyosarcoma (muscle primary) |
| SJSA-1 | |
| SK-CO-1 | disease: colorectal adenocarcinoma (colon primary) |
| SK-HEP-1 | Human liver adenocarcinoma cell line; established from the ascites of a 52-year-old Caucasian man in 1971. |
| SK-LMS-1 | |
| SK-LU-1 | Non-small cell lung cancer cell line. |
| SK-MEL-2 | |
| SK-MEL-24 | disease: malignant melanoma |
| SK-MEL-28 | |
| SK-MEL-3 | |
| SK-MEL-30 | Human melanoma derived from tumor tissue (subcutis metastasis) of a 67-year-old Caucasian man with malignant melanoma in 1975. |
| SK-MEL-5 | Human caucasian skin melanoma cell line; established from a 24 year old Caucasian female. Derived from: axillary node. |
| SK-MES-1 | |
| SK-MG-1 | |
| SK-MM-2 | |
| SK-N-AS | |
| SK-N-DZ | Neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a 2 years old caucasian female child with poorly differentiated embryonal neuroblastoma. |
| SK-N-FI | Neuroblastoma cell line; derived in 1979 from a bone marrow metastasis from a 11 year old Caucasian male with poorly differentiated embryonal neuroblastoma. |
| SK-NEP-1 | disease: Wilmstumor (kidney primary) |
| SK-OV-3 | |
| SK-UT-1 | |
| SKG-IIIa | A immortal human uterine cervix-derived cell line cell that has the characteristics: Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462(Deposited from Tohoku Univ.). |
| SKM-1 | |
| SN12C | Human renal cell carcinoma cell line. |
| SNG-M | |
| SNU-387 | |
| SNU-423 | |
| SNU-449 | |
| SNU-475 | |
| SNU-C1 | disease: adenocarcinoma colon primary) |
| SNU-C2B | disease: colorectal carcinoma |
| SR | |
| ST486 | disease: Burkitts lymphoma |
| SU-DHL-1 | |
| SUP-T1 | Human T cell lymphoma cell line; established from the pleural effusion of an 8-year-old boy with T-lymphoblastic lymphoma in relapse. |
| SW1088 | |
| SW1116 | |
| SW13 | |
| SW1417 | |
| SW1463 | |
| SW1573 | |
| SW1710 | disease: carcinoma, transitional cell |
| SW1783 | disease: astrocytoma |
| SW1990 | |
| SW48 | |
| SW620 | |
| SW626 | Human, ovary, adenocarcinoma cell line. |
| SW684 | disease: fibrosarcoma |
| SW780 | disease: transitional cell carcinoma |
| SW837 | |
| SW872 | |
| SW900 | |
| SW948 | |
| SW954 | disease: squamous cell carcinoma |
| SW962 | disease: carcinoma (vulva primary) |
| SW982 | disease: synovial sarcoma |
| T-24 | |
| T47D | |
| T84 | |
| T98G | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.). |
| TALL-1 | A immortal human bone marrow-derived cell line cell that has the characteristics: Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.). |
| TC-YIK | A immortal human uterine cervix-derived cell line cell that has the characteristics: Integrating HPV16, neurosecretory granules(+) |
| TCCSUP | disease: transitional cell carcinoma |
| TE-1 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0462(Deposited from Tohoku Univ.). |
| TE-10 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.). |
| TE-11 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262(Deposited from Tohoku Univ.). |
| TE-12 | |
| TE-15 | Human esophageal squamous cell carcinoma cell line. |
| TE-5 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.). |
| TE-6 | A immortal human esophagus-derived cell line cell that has the characteristics: Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cyclin and MC210. TKG0257 (Deposited from Tohoku Univ.). |
| TE-8 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259(Deposited from Tohoku Univ.). |
| TE-9 | A immortal human esophagus-derived cell line cell that has the characteristics: Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.). |
| TGBC11TKB | A immortal human stomach-derived cell line cell that has the characteristics: Japanese gastric cancer, lymph node metastated. |
| TGBC1TKB | A immortal human cell line cell that has the characteristics: Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Cell growth is slow. |
| TGBC24TKB | A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma established from metastated ascite. Cell growth is slow. |
| TGW | |
| TK10 | TK-10 was derived from a specimen of primary RCC obtained following a left radical nephrectomy in a 43-year-old male on August 21, 1980. |
| TT | |
| TUR | disease: histiocytic lymphoma; neomycin resistant |
| TYK-nu | |
| U-118-MG | Human neuronal glioblastoma (grade III) cell line. |
| U-2-OS | |
| U-266 | Human multiple myeloma cell line; established from the peripheral blood of a 53-year-old man with IgE-secreting myeloma (refractory, terminal) in 1968. |
| U-698-M | disease: lymphoma, B cell |
| U-87-MG | Human, Caucasian, brain, glioblastoma-astrocytoma cell line Morphology: epithelial-like; Species: human, Caucasian female 44 years old; Tissue: brain; Tumor: glioblastoma-astrocytoma. |
| U031 | |
| U251 | Human glioma cell line. Morphology: glial; Species: human; Tumor: glioma. |
| UACC-257 | |
| UACC-62 | |
| UACC-812 | disease: ductal carcinoma |
| UM-UC-3 | |
| UMC-11 | disease: carcinoid |
| VA-ES-BJ | disease: carcinoma, epithelioid (bone primary) |
| VM-CUB-1 | disease: carcinoma, transitional cell |
| VMRC-RCZ | Human renal carcinoma cell line. |
| WM-115 | |
| WSU-NHL | |
| YAPC | |
| YH-13 | |
| YKG-1 | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.). |
| ZR-75-30 |
